Millennium Management’s Orion Biotech Opportunities Corp. Units ORIAU Stock Holding History

Millennium Management’s Portfolio ORIAU Stock Details ORIAU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-32,826	Closed	-$323K	–	7334
2022 Q3	$323K	Sell	32,826 -3,227	-9%	-$31.8K	﹤0.01%	5303
2022 Q2	$355K	Hold	36,053	–	–	﹤0.01%	5226
2022 Q1	$352K	Hold	36,053	–	–	﹤0.01%	5411
2021 Q4	$355K	Sell	36,053 -250,000	-87%	-$2.49M	﹤0.01%	5365
2021 Q3	$2.83M	Sell	286,053 -163,647	-36%	-$1.63M	﹤0.01%	3506
2021 Q2	$4.52M	Buy	+449,700	New	+$4.53M	﹤0.01%	2892

Other funds holding ORIAU

JNE Partners London, United Kingdom $244M AUM 15.73% 1-Year Est. Return

SIA

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

GAM

Gritstone Asset Management Bethesda, Maryland $93.6M AUM 11.18% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Millennium Management's ORIAU Position: Q4 2022 in Review

Millennium Management sold out of Orion Biotech Opportunities Corp. Units (ORIAU) in Q4 2022, closing a stake of 32,826 shares — an estimated $323K sold.

Millennium Management first reported a position in ORIAU in Q2 2021 and held it in 6 quarters. The position peaked at $4.52M in Q2 2021. 6 funds tracked by Wall St. Rank hold ORIAU as of Q4 2022.

Millennium Management reported no remaining Orion Biotech Opportunities Corp. Units position as of Q4 2022 after selling out during the quarter.
Millennium Management sold 32,826 Orion Biotech Opportunities Corp. Units shares in Q4 2022, an estimated $323K.
Millennium Management first reported a position in Orion Biotech Opportunities Corp. Units in Q2 2021 and held it in 6 quarters.
Millennium Management's Orion Biotech Opportunities Corp. Units position peaked at $4.52M in Q2 2021.
6 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Units as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.